Anto Biosciences Analysis: $500K Raised
What is Anto Biosciences?
Anto Biosciences is developing a multimodal foundation model for microbial communities, focusing on making the gut microbiome computable. The company aims to predict drug toxicity and improve drug response by understanding the interactions between drugs and the gut microbiome.
Location
San Francisco, United States
Employees
1-10
Founded
2025
Industry
Healthcare, Drug Discovery, FinTech, Analytics, Consumer, Therapeutics
Extruct Category
Health
Founders LinkedIn
- Arvid E. Gollwitzer: https://www.linkedin.com/in/arvid-gollwitzer/
- David de Gruijl: https://www.linkedin.com/in/daviddegruijl
Sub-cluster
biomarker discovery
YC Batch
F25
YC Partner
Nicolas Dessaigne
How much Anto Biosciences raised
Funding - $500K
Who are the founders of Anto Biosciences
DD
David de Gruijl
Founder at Anto Biosciences (YC F25)
See something that needs updating? Suggest edits to this profile.